Aristotle Atlantic Partners’s Eli Lilly LLY Stock Holding History

Aristotle Atlantic Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.1M	Sell	28,380 -214	-0.7%	-$217K	1.22%	28
2025 Q4	$30.7M	Sell	28,594 -39,396	-58%	-$37.7M	1.41%	20
2025 Q3	$51.9M	Buy	67,990 +5,500	+9%	+$4.09M	1.5%	18
2025 Q2	$48.7M	Buy	62,490 +19,294	+45%	+$15M	1.48%	17
2025 Q1	$35.7M	Buy	43,196 +2,019	+5%	+$1.68M	1.2%	25
2024 Q4	$31.8M	Buy	41,177 +15,608	+61%	+$12.9M	1%	24
2024 Q3	$22.7M	Buy	25,569 +2,792	+12%	+$2.51M	0.7%	38
2024 Q2	$20.6M	Buy	22,777 +14,503	+175%	+$11.6M	0.67%	43
2024 Q1	$6.44M	Buy	8,274 +2,165	+35%	+$1.54M	0.21%	69
2023 Q4	$3.56M	Buy	6,109 +5,609	+1,122%	+$3.27M	0.13%	72
2023 Q3	$269K	Hold	500	–	–	0.01%	94
2023 Q2	$234K	Buy	+500	New	+$210K	0.01%	99

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aristotle Atlantic Partners's LLY Position: Q1 2026 in Review

Aristotle Atlantic Partners reduced its Eli Lilly (LLY) stake by 0.75% in Q1 2026, selling an estimated $217K and leaving 28,380 shares worth $26.1M. The position accounts for 1.22% of the portfolio, ranked #28.

Aristotle Atlantic Partners first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $51.9M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Aristotle Atlantic Partners held 28,380 shares of Eli Lilly worth $26.1M as of Q1 2026.
Aristotle Atlantic Partners sold 214 Eli Lilly shares in Q1 2026, an estimated $217K.
Eli Lilly made up 1.22% of Aristotle Atlantic Partners's portfolio in Q1 2026, its #28 holding.
Aristotle Atlantic Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Aristotle Atlantic Partners's Eli Lilly position peaked at $51.9M in Q3 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2026, filed 15 May 2026.